Pieri,
Scott,
Eastwood,
Clark,
Cruz,
Zmuda,
Laakso,
Lehtimäki,
Cauley,
Lacroix,
Cayón,
Pascual,
Kang,
Wilson,
Huang,
Woodworth,
Offit,
Markovic,
Röyttä,
Arp,
Halldorsson,
Watson,
Leyva-Cobián,
Castillo,
Ferrell,
González,
Colin,
Corbo,
Gansberger,
Pols,
Rinne,
Jaakkola,
Brown,
Biswas,
Kajinami,
Kalush,
Schuit,
Hofman,
Gambina,
Weel,
Brousseau,
Niu,
Lehtimäki,
Ruiz de Alegría,
van der Klift,
Knuuti,
Snell,
White,
van Duijn,
Fang,
Muñoz,
Schaefer,
Ruggeri,
Weissfeld,
Mattila,
Trump,
van Meurs,
Pardee,
Laippala,
Sánchez-Velasco,
Valle,
Bravo,
Nuutila,
Gold,
Dean,
Parl,
Koivula,
Bergeron,
van Leeuwen,
Broder,
Ordovas,
Mitra,
Murphy,
Vesalainen,
Shea,
Lamon-Fava,
Oterino,
Chen,
Uitterlinden,
Lee,
Modugno,
Janatuinen,
Oesterreich,
Leclercq,
Lippert,
Scacchi,
Ellis,
Townson,
Laaksonen,
Mattila,
Bergink,
Alonso-Arranz,
- Estrogen receptor alpha polymorphisms associated with susceptibility to hepatocellular carcinoma in hepatitis B virus carriers. Zhai, Y., Zhou, G., Deng, G., Xie, W., Dong, X., Zhang, X., Yu, L., Yang, H., Yuan, X., Zhang, H., Zhi, L., Yao, Z., Shen, Y., Qiang, B., He, F. Gastroenterology (2006)
- Estrogen receptor genotypes and haplotypes associated with breast cancer risk. Gold, B., Kalush, F., Bergeron, J., Scott, K., Mitra, N., Wilson, K., Ellis, N., Huang, H., Chen, M., Lippert, R., Halldorsson, B.V., Woodworth, B., White, T., Clark, A.G., Parl, F.F., Broder, S., Dean, M., Offit, K. Cancer Res. (2004)
- Allelic variants of aromatase and the androgen and estrogen receptors: toward a multigenic model of prostate cancer risk. Modugno, F., Weissfeld, J.L., Trump, D.L., Zmuda, J.M., Shea, P., Cauley, J.A., Ferrell, R.E. Clin. Cancer Res. (2001)
- Estrogen receptor alpha (ESR1) mutant A908G is not a common feature in benign and malignant proliferations of the breast. Tebbit, C.L., Bentley, R.C., Olson, J.A., Marks, J.R. Genes Chromosomes Cancer (2004)
- The transcription factor snail mediates epithelial to mesenchymal transitions by repression of estrogen receptor-alpha. Dhasarathy, A., Kajita, M., Wade, P.A. Mol. Endocrinol. (2007)
- Investigation of the estrogen receptor-alpha gene with type 2 diabetes and/or nephropathy in African-American and European-American populations. Gallagher, C.J., Keene, K.L., Mychaleckyj, J.C., Langefeld, C.D., Hirschhorn, J.N., Henderson, B.E., Gordon, C.J., Freedman, B.I., Rich, S.S., Bowden, D.W., Sale, M.M. Diabetes (2007)
- Estrogen receptor alpha (ESR1) gene amplification is frequent in breast cancer. Holst, F., Stahl, P.R., Ruiz, C., Hellwinkel, O., Jehan, Z., Wendland, M., Lebeau, A., Terracciano, L., Al-Kuraya, K., Jänicke, F., Sauter, G., Simon, R. Nat. Genet. (2007)
- Variation in the ESR1 and ESR2 genes and genetic susceptibility to anorexia nervosa. Eastwood, H., Brown, K.M., Markovic, D., Pieri, L.F. Mol. Psychiatry (2002)
- Estrogen receptor 1 gene (ESR1) variants in panic disorder. Sand, P.G., Schlurmann, K., Luckhaus, C., Götz, M., Stöber, G., Lesch, K.P., Riederer, P., Franke, P., Maier, W., Nöthen, M.M., Propping, P., Fritze, J., Deckert, J. Am. J. Med. Genet. (2002)
- Lack of association between an estrogen receptor 1 gene polymorphism and Parkinson's disease with dementia. Mattila, K.M., Rinne, J.O., Röyttä, M., Laippala, P., Lehtimäki, T. Acta neurologica Scandinavica. (2002)
- Reduced glucocorticoid and estrogen receptor alpha messenger ribonucleic acid levels in the amygdala of patients with major mental illness. Perlman, W.R., Webster, M.J., Kleinman, J.E., Weickert, C.S. Biol. Psychiatry (2004)
- Association of estrogen receptor alpha (ESR1) PvuII and XbaI polymorphisms with sporadic Alzheimer's disease and their effect on apolipoprotein E concentrations. Corbo, R.M., Gambina, G., Ruggeri, M., Scacchi, R. Dementia and geriatric cognitive disorders. (2006)
- Mechanisms of estrogen action. Nilsson, S., Mäkelä, S., Treuter, E., Tujague, M., Thomsen, J., Andersson, G., Enmark, E., Pettersson, K., Warner, M., Gustafsson, J.A. Physiol. Rev. (2001)
- Sex steroids and bone. Compston, J.E. Physiol. Rev. (2001)
- The SRC-3/AIB1 coactivator is degraded in a ubiquitin- and ATP-independent manner by the REGgamma proteasome. Li, X., Lonard, D.M., Jung, S.Y., Malovannaya, A., Feng, Q., Qin, J., Tsai, S.Y., Tsai, M.J., O'Malley, B.W. Cell (2006)
- Estrogen and progesterone receptor gene polymorphisms and sporadic breast cancer risk: a Spanish case-control study. Fernández, L.P., Milne, R.L., Barroso, E., Cuadros, M., Arias, J.I., Ruibal, A., Benítez, J., Ribas, G. Int. J. Cancer (2006)
- Age-dependent methylation of ESR1 gene in prostate cancer. Li, L.C., Shiina, H., Deguchi, M., Zhao, H., Okino, S.T., Kane, C.J., Carroll, P.R., Igawa, M., Dahiya, R. Biochem. Biophys. Res. Commun. (2004)
- Multilocus analyses of estrogen-related genes reveal involvement of the ESR1 gene in male infertility and the polygenic nature of the pathology. Galan, J.J., Buch, B., Cruz, N., Segura, A., Moron, F.J., Bassas, L., Martinez-Pineiro, L., Real, L.M., Ruiz, A. Fertil. Steril. (2005)
- p27(Kip1) induces quiescence and growth factor insensitivity in tamoxifen-treated breast cancer cells. Carroll, J.S., Lynch, D.K., Swarbrick, A., Renoir, J.M., Sarcevic, B., Daly, R.J., Musgrove, E.A., Sutherland, R.L. Cancer Res. (2003)
- Raloxifene, a selective estrogen receptor modulator, induces apoptosis in androgen-responsive human prostate cancer cell line LNCaP through an androgen-independent pathway. Kim, I.Y., Seong, d.o. .H., Kim, B.C., Lee, D.K., Remaley, A.T., Leach, F., Morton, R.A., Kim, S.J. Cancer Res. (2002)
- Association of 5' estrogen receptor alpha gene polymorphisms with bone mineral density, vertebral bone area and fracture risk. van Meurs, J.B., Schuit, S.C., Weel, A.E., van der Klift, M., Bergink, A.P., Arp, P.P., Colin, E.M., Fang, Y., Hofman, A., van Duijn, C.M., van Leeuwen, J.P., Pols, H.A., Uitterlinden, A.G. Hum. Mol. Genet. (2003)
- Mutation of GATA3 in human breast tumors. Usary, J., Llaca, V., Karaca, G., Presswala, S., Karaca, M., He, X., Langerød, A., Kåresen, R., Oh, D.S., Dressler, L.G., Lønning, P.E., Strausberg, R.L., Chanock, S., Børresen-Dale, A.L., Perou, C.M. Oncogene (2004)
- Estrogen receptor alpha gene polymorphisms are associated with the angiographic extent of coronary artery disease. Rokach, A., Pollak, A., Rosen, L., Friedlander, Y., Blumenfeld, A., Reznik, L., Dresner-Pollak, R. J. Clin. Endocrinol. Metab. (2005)
- Use of DNA from human stools to detect aberrant CpG island methylation of genes implicated in colorectal cancer. Belshaw, N.J., Elliott, G.O., Williams, E.A., Bradburn, D.M., Mills, S.J., Mathers, J.C., Johnson, I.T. Cancer Epidemiol. Biomarkers Prev. (2004)
- Genetic and environmental determinants of bone mineral density in Chinese women. Lau, H.H., Ng, M.Y., Ho, A.Y., Luk, K.D., Kung, A.W. Bone (2005)
- Relevance of breast cancer cell lines as models for breast tumours: an update. Lacroix, M., Leclercq, G. Breast Cancer Res. Treat. (2004)
- Phytoestrogen exposure correlation with plasma estradiol in postmenopausal women in European Prospective Investigation of Cancer and Nutrition-Norfolk may involve diet-gene interactions. Low, Y.L., Taylor, J.I., Grace, P.B., Dowsett, M., Scollen, S., Dunning, A.M., Mulligan, A.A., Welch, A.A., Luben, R.N., Khaw, K.T., Day, N.E., Wareham, N.J., Bingham, S.A. Cancer Epidemiol. Biomarkers Prev. (2005)
- Gender-specific effects of estrogen receptor alpha gene haplotype on high-density lipoprotein cholesterol response to atorvastatin: interaction with apolipoprotein AI gene polymorphism. Kajinami, K., Brousseau, M.E., Lamon-Fava, S., Ordovas, J.M., Schaefer, E.J. Atherosclerosis (2005)
- Effects of anastrozole on the intratumoral gene expression in locally advanced breast cancer. Kristensen, V.N., Sørlie, T., Geisler, J., Yoshimura, N., Linegjaerde, O.C., Glad, I., Frigessi, A., Harada, N., Lønning, P.E., Børresen-Dale, A.L. J. Steroid Biochem. Mol. Biol. (2005)
- Oestrogen receptor gene variation is a determinant of coronary reactivity in healthy young men. Lehtimäki, T., Laaksonen, R., Mattila, K.M., Janatuinen, T., Vesalainen, R., Nuutila, P., Laakso, J., Jaakkola, O., Koivula, T., Knuuti, J. Eur. J. Clin. Invest. (2002)
- Potentiation of ICI182,780 (Fulvestrant)-induced estrogen receptor-alpha degradation by the estrogen receptor-related receptor-alpha inverse agonist XCT790. Lanvin, O., Bianco, S., Kersual, N., Chalbos, D., Vanacker, J.M. J. Biol. Chem. (2007)
- Estrogen receptor alpha gene variants associate with type 2 diabetes and fasting plasma glucose. Dahlman, I., Vaxillaire, M., Nilsson, M., Lecoeur, C., Gu, H.F., Cavalcanti-Proença, C., Efendic, S., Ostenson, C.G., Brismar, K., Charpentier, G., Gustafsson, J.A., Froguel, P., Dahlman-Wright, K., Steffensen, K.R. Pharmacogenet. Genomics (2008)
- Coassociation of estrogen receptor and p160 proteins predicts resistance to endocrine treatment; SRC-1 is an independent predictor of breast cancer recurrence. Redmond, A.M., Bane, F.T., Stafford, A.T., McIlroy, M., Dillon, M.F., Crotty, T.B., Hill, A.D., Young, L.S. Clin. Cancer Res. (2009)
- Human TAFII30 is present in a distinct TFIID complex and is required for transcriptional activation by the estrogen receptor. Jacq, X., Brou, C., Lutz, Y., Davidson, I., Chambon, P., Tora, L. Cell (1994)
- Rapid estrogen-induced phosphorylation of the SRC-3 coactivator occurs in an extranuclear complex containing estrogen receptor. Zheng, F.F., Wu, R.C., Smith, C.L., O'Malley, B.W. Mol. Cell. Biol. (2005)
- Epidermal growth factor binding by breast tumor biopsies and relationship to estrogen receptor and progestin receptor levels. Fitzpatrick, S.L., Brightwell, J., Wittliff, J.L., Barrows, G.H., Schultz, G.S. Cancer Res. (1984)
- p300 Modulates the BRCA1 inhibition of estrogen receptor activity. Fan, S., Ma, Y.X., Wang, C., Yuan, R.Q., Meng, Q., Wang, J.A., Erdos, M., Goldberg, I.D., Webb, P., Kushner, P.J., Pestell, R.G., Rosen, E.M. Cancer Res. (2002)
- Gamma synuclein, a novel heat-shock protein-associated chaperone, stimulates ligand-dependent estrogen receptor alpha signaling and mammary tumorigenesis. Jiang, Y., Liu, Y.E., Goldberg, I.D., Shi, Y.E. Cancer Res. (2004)
- Estrogen receptor protein interaction with phosphatidylinositol 3-kinase leads to activation of phosphorylated Akt and extracellular signal-regulated kinase 1/2 in the same population of cortical neurons: a unified mechanism of estrogen action. Mannella, P., Brinton, R.D. J. Neurosci. (2006)
- Serine 167 is the major estradiol-induced phosphorylation site on the human estrogen receptor. Arnold, S.F., Obourn, J.D., Jaffe, H., Notides, A.C. Mol. Endocrinol. (1994)
- Regulation of estrogen receptor transcriptional enhancement by the cyclin A/Cdk2 complex. Trowbridge, J.M., Rogatsky, I., Garabedian, M.J. Proc. Natl. Acad. Sci. U.S.A. (1997)
- Phospho-serine-118 estrogen receptor-alpha expression is associated with better disease outcome in women treated with tamoxifen. Murphy, L.C., Niu, Y., Snell, L., Watson, P. Clin. Cancer Res. (2004)
- PS2 protein in breast carcinomas: cut-off value of estrogen-regulated expression. Nikolić-Vukosavljević, D., Grujić-Adanja, G., Janković, R., Nesković-Konstantinović, Z., Branković-Magić, M. Neoplasma (2001)
- Expression of Pit-1 and estrogen receptor messenger RNA in prolactin-producing pituitary adenomas. Sanno, N., Teramoto, A., Matsuno, A., Takekoshi, S., Itoh, J., Osamura, R.Y. Mod. Pathol. (1996)
- Ligand-independent recruitment of steroid receptor coactivators to estrogen receptor by cyclin D1. Zwijsen, R.M., Buckle, R.S., Hijmans, E.M., Loomans, C.J., Bernards, R. Genes Dev. (1998)
- Correlation of insulin-like growth factor-binding protein-3 messenger RNA with protein expression in primary breast cancer tissues: detection of higher levels in tumors with poor prognostic features. Rocha, R.L., Hilsenbeck, S.G., Jackson, J.G., Lee, A.V., Figueroa, J.A., Yee, D. J. Natl. Cancer Inst. (1996)
- Epidermal growth factor-induced nuclear factor kappa B activation: A major pathway of cell-cycle progression in estrogen-receptor negative breast cancer cells. Biswas, D.K., Cruz, A.P., Gansberger, E., Pardee, A.B. Proc. Natl. Acad. Sci. U.S.A. (2000)
- Plasma membrane localization and function of the estrogen receptor alpha variant (ER46) in human endothelial cells. Li, L., Haynes, M.P., Bender, J.R. Proc. Natl. Acad. Sci. U.S.A. (2003)
- Steroid hormone receptors compete for factors that mediate their enhancer function. Meyer, M.E., Gronemeyer, H., Turcotte, B., Bocquel, M.T., Tasset, D., Chambon, P. Cell (1989)
- Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase. Kato, S., Endoh, H., Masuhiro, Y., Kitamoto, T., Uchiyama, S., Sasaki, H., Masushige, S., Gotoh, Y., Nishida, E., Kawashima, H., Metzger, D., Chambon, P. Science (1995)
- Nuclear receptor function requires a TFTC-type histone acetyl transferase complex. Yanagisawa, J., Kitagawa, H., Yanagida, M., Wada, O., Ogawa, S., Nakagomi, M., Oishi, H., Yamamoto, Y., Nagasawa, H., McMahon, S.B., Cole, M.D., Tora, L., Takahashi, N., Kato, S. Mol. Cell (2002)
- Levels of hypoxia-inducible factor-1 alpha during breast carcinogenesis. Bos, R., Zhong, H., Hanrahan, C.F., Mommers, E.C., Semenza, G.L., Pinedo, H.M., Abeloff, M.D., Simons, J.W., van Diest, P.J., van der Wall, E. J. Natl. Cancer Inst. (2001)
- The association between heel ultrasound and hormone replacement therapy is modulated by a two-locus vitamin D and estrogen receptor genotype. Giguère, Y., Dodin, S., Blanchet, C., Morgan, K., Rousseau, F. J. Bone Miner. Res. (2000)
- Human controlled ovarian hyperstimulation outcome is a polygenic trait. de Castro, F., Morón, F.J., Montoro, L., Galán, J.J., Hernández, D.P., Padilla, E.S., Ramírez-Lorca, R., Real, L.M., Ruiz, A. Pharmacogenetics (2004)
- Association of migraine and ESR1 G325C polymorphism. Oterino, A., Pascual, J., Ruiz de Alegría, C., Valle, N., Castillo, J., Bravo, Y., González, F., Sánchez-Velasco, P., Cayón, A., Leyva-Cobián, F., Alonso-Arranz, A., Muñoz, P. Neuroreport (2006)
- Novel role of the RET finger protein in estrogen receptor-mediated transcription in MCF-7 cells. Townson, S.M., Kang, K., Lee, A.V., Oesterreich, S. Biochem. Biophys. Res. Commun. (2006)